Home Stock

Stock Research: ScinoPharm

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

ScinoPharm

TSEC:1789 TW0001789006
33
  • Value
    26
  • Growth
    32
  • Safety
    Safety
    76
  • Combined
    32
  • Sentiment
    51
  • 360° View
    360° View
    33
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ScinoPharm Taiwan Ltd. researches, develops, manufactures, and sells active pharmaceutical ingredients. The company operates in the pharmaceutical industry. It serves markets in the Americas, Europe, Australia, and Asia. In the last fiscal year, the company had a market cap of $445 million, profits of $40 million, and revenue of $104 million. The number of employees is not available.

more
Strongest Rank Stock Returns
Weakest Rank Market Pulse
Country Taiwan
Industry Pharmaceuticals
Size X-Small
Website scinopharm.com.tw
Index
FTSE Taiwan
ScinoPharm stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 18 24 41
Growth
32 37 9 81
Safety
Safety
76 69 78 67
Sentiment
51 42 22 1
360° View
360° View
33 33 14 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
39 12 20 24
Opinions Change
50 50 1 50
Pro Holdings
n/a 40 20 41
Market Pulse
91 87 100 1
Sentiment
51 42 22 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 18 24 41
Growth
32 37 9 81
Safety Safety
76 69 78 67
Combined
32 30 20 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 12 7 36
Price vs. Earnings (P/E)
21 16 13 26
Price vs. Book (P/B)
59 35 41 65
Dividend Yield
59 36 49 53
Value
26 18 24 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
71 66 26 96
Profit Growth
27 20 10 84
Capital Growth
65 28 26 8
Stock Returns
14 48 51 61
Growth
32 37 9 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
73 67 71 68
Refinancing
64 49 65 67
Liquidity
67 55 63 41
Safety Safety
76 69 78 67

Similar Stocks

Discover high‑ranked alternatives to ScinoPharm and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Shionogi

TSE:4507
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Asustek Computer

TSEC:2357
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Ono Pharmaceutical

TSE:4528
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The value case is weak (expensive and low Growth Rank), but sentiment is strong and financing is safe. This scenario may indicate future growth not yet in current financials. This is a speculative choice for investors with a high-risk appetite who are betting on the positive sentiment and safe financing to sustain a long-term turnaround.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews